Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers

NCT02551744 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Peptic Ulcer

Interventions

DRUG: histamine-2 receptor antagonist group
DRUG: proton pump inhibitor group

Sponsor

Kaohsiung Veterans General Hospital.